Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model. Academic Article uri icon

Overview

publication date

  • May 1, 2001

Research

keywords

  • Biological Therapy
  • Simplexvirus
  • Urinary Bladder Neoplasms

Identity

Scopus Document Identifier

  • 0035349907

PubMed ID

  • 11344122

Additional Document Info

volume

  • 15

issue

  • 7